Is Navan Inc (NAVN) a risky stock?
As of July 27, 2026, Clavix grades Navan Inc (NAVN) C- for risk, a composite score of 53 out of 100 on an A+ to F scale, which puts NAVN in the "average" band. The grade is a risk read for educational purposes, not a buy or sell recommendation.
Grade as of July 27, 2026. Clavix regrades every trading day.
NAVN price, last 3 months
NAVN's daily closes over the past three months. Clavix reads risk from the fundamentals and news behind the price, not the line itself.
The five risk dimensions behind NAVN's grade
Each Clavix grade is a composite of five independent reads. Higher is safer. Here is how NAVN scores on each, as of July 27, 2026.
What's moving NAVN's risk right now
Company-specific signals Clavix flags behind NAVN's current grade, drawn from recent news and filings as of July 27, 2026.
Drug discovery company Evotec chose Navan to manage corporate travel booking and payments across its global operations. The deal adds a new enterprise customer in the pharmaceutical sector and signals demand for Navan's platform among large multinationals.
A global drug discovery company is partnering with Navan to use its corporate expense management platform. The agreement gives Navan a foothold in the pharmaceutical and biotech sector and supports expansion of its enterprise customer base.
Industry data shows US business travel recovering faster than leisure travel. That split favors Navan, whose platform is built around corporate travel, and supports continued growth in its enterprise customer pipeline.
Recent NAVN news
The latest headlines Clavix ingested for Navan Inc, newest first. These feed the news-sentiment dimension of NAVN's grade.
-
Evotec, a global drug discovery and development company, has selected Navan to manage its complete corporate Travel and Expense (T&E) program across its top global markets.
-
A global drug discovery leader has partnered with Navan (NAVN) to drive operational excellence and eliminate manual expense reporting. The full details of the partnership were not disclosed in the provided article.
-
Navan announced that Evotec, a global drug discovery and development company, has selected Navan to manage its complete corporate Travel and Expense (T&E) program across its top global markets.
What a C- grade means
On the Clavix A+ to F scale, NAVN's composite of 53 falls in the C band (50–64), read as "average." The scale is fixed, so the meaning never moves.
This page is generated from Clavix's own risk model and is for educational purposes only. It is not investment advice or a recommendation to buy or sell NAVN or any security. Grades are risk indicators, not predictions of return. Data may be delayed.